Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Wellgistics Health Inc ( (WGRX) ).
On August 20, 2025, Wellgistics Health, Inc. announced its financial results for the second fiscal quarter ended June 30, 2025, reporting a revenue of $18.65 million for the first half of 2025, up from $18.25 million in the same period of 2024. Since its IPO in February 2025, the company has focused on operational integration, governance, and growth initiatives, including consolidating operations, reducing costs, upgrading systems, and expanding partnerships. These efforts have positioned Wellgistics Health to enhance its direct-to-patient delivery model, leveraging its extensive network to improve access and affordability in therapeutic areas such as diabetes and chronic pain.
More about Wellgistics Health Inc
Wellgistics Health, Inc. is a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment. The company connects over 6,500 independent pharmacies and 200 U.S. manufacturers, offering wholesale distribution and AI-driven hub services. It positions itself as a PBM-agnostic alternative, aiming to restore access, transparency, and trust in U.S. healthcare.
Average Trading Volume: 2,414,776
Technical Sentiment Signal: Strong Sell
Current Market Cap: $65.91M
See more insights into WGRX stock on TipRanks’ Stock Analysis page.